Combination Low Air Loss with Pulsation for Advanced Wound Healing
The DermaFloat® LAL is a unique therapy system that provides pressure redistribution by combining low air loss with pulsation. Low air loss therapy has been demonstrated to reduce the risk of pressure ulcers as well as being a valuable aid in the treatment of pressure ulcers. The pulsation feature may provide additional resident comfort and enhance the lymphatic system. The DermaFloat LAL is designed as a mattress replacement system for residents weighing up to 500 lbs.
Easy to use, therapeutic low air loss mattress replacement system for the treatment and prevention of pressure ulcers up to Stage IV. Mattress available in standard and bariatric sizes.
DermaFloat Low Air Loss features:
True low air loss wicks away moisture to prevent skin maceration
Twenty individual cells help to evenly distribute resident’s weight and maximize pressure redistribution
Low shear and low friction therapy pad is treated with an antibacterial and antifungal agent and is fluid proof and moisture vapor permeable
Two-inch lower safety mattress for resident transport and power failure; stays inflated for up to 12 hours to prevent bottoming out
CairRails risk management side air bolsters
42" wide mattress enhances resident comfort and allows caregiver extra room to provide necessary procedures
Three operation modes: Autofirm, Therapy and Pulsate
CPR quick deflation
Specifications:
Maximum Weight Capacity: 500 lbs.
Dimensions: 36” W x 80” L x 10” D, 42” W x 80” L x 10” D
Number of Zones: 3
Number of Therapy Cells: 20 horizontal cells
Depth of Therapy Cells: 8”
Lower Safety Cell Depth: 2”
CPR Quick Deflation: Yes
CairRails/Side Bolsters: CairRails
Control Unit Dimensions: 7.5” W x 12.25” H x 5.5” D
Control Unit Modes of Operation: Autofirm, Therapy and Pulsate
Therapy / Comfort Settings: 8
Clinical indications
Pressure redistribution: Stage I - IV Pressure Ulcers, Moisture Management Required, Rehabilitation, Burns, Neurology, Dermatology, Amputations